China Headquarters

US Division

PIPELINE

According to specific application needs

providing abundant innovative antibody drug candidates

>
PIPELINE

PIPELINE

Code Target Disease Area Discovery Lead Optimization Preclinical IND
BSI-001 Known Breast cancer

 

BSI-003 New Cancer target therapy

 

BSI-004 Known Immuno-oncology therapy

 

BSI-005 Known Immuno-oncology therapy

 

BSI-006 Known Immuno-oncology therapy

 

BSI-008 New Immuno-oncology therapy

 

BSI-009 New Immuno-oncology therapy

 

BSI-010 New Immuno-oncology therapy

 

BSI-012 New Immuno-oncology therapy

 

BSI-013 New Immuno-oncology therapy

 

BSI-015 New Immuno-oncology therapy

 

BSI-016 New Immuno-oncology therapy

 

BSI-018 New Immuno-oncology therapy

 

BSI-019 New Immuno-oncology therapy

 

BSI-021 Known Immuno-oncology therapy

 

BSI-023 New ADC carrier

 

BSI-024 Known Cardiovascular and bone diseases

 

BSI-030 New Cardiovascular and bone diseases

 

BSI-033 New Immuno-oncology therapy

 

BSI-034 New Immuno-oncology therapy